| [1] |
马丹，杨帆，廖专，等．中国早期食管癌筛查及内镜诊治专家共识意见（2014年，北京）[J]．胃肠病学, 2015(4):220-240.
|
| [2] |
Shiota S, Singh S, Anshasi A, et al. Prevalence of Barrett's Esophagus in Asian Countries: A Systematic Review and Meta-analysis[J]. Clin Gastroenterol Hepatol, 2015, 13(11):1907-1918.
|
| [3] |
Sharma P, Dent J, Armstrong D, et al. The Development and Validation of an Endoscopic Grading System for Barrett's Esophagus:The Prague C&M Criteria [J]. Gastroenterology, 2006,131(5):1392-1399.
|
| [4] |
Kinjo T, Kusano C, Oda I, et al. Prague C&M and Japanese criteria: shades of Barrett's esophagus endoscopic diagnosis [J]. J Gastroenterol, 2010,45(10):1039-1044.
|
| [5] |
Shaheen NJ, Falk GW, Iyer PG, et al. ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus[J]. Am J Gastroenterol, 2016,111(1):30-50, 51.
|
| [6] |
李鹏，王拥军，陈光勇，等．中国巴雷特食管及其早期腺癌筛查与诊治共识（2017万宁) [J]．中国实用内科杂志, 2017(09):798-809.
|
| [7] |
房殿春，林三仁，于中麟，等. Barrett食管诊治共识（修订版2011年6月重庆）[J]．胃肠病学, 2011(08):485-486.
|
| [8] |
Harrison R, Perry I, Haddadin W, et al. Detection of Intestinal Metaplasia in Barrett's Esophagus: An Observational Comparator Study Suggests the Need for a Minimum of Eight Biopsies [J]. Am J of Gastroenterol, 2007, 102(6):1154-1161.
|
| [9] |
Naini BV, Chak A, Ali MA, et al. Barrett's oesophagus diagnostic criteria: endoscopy and histology [J]. Best Practice Res Clin Gastroenterol, 2015, 29(1):77-96.
|
| [10] |
Bandla S, Peters JH, Ruff D, et al. Comparison of Cancer-Associated Genetic Abnormalities in Columnar-Lined Esophagus Tissues With and Without Goblet Cells [J]. Ann Surg, 2014, 260(1):72-80.
|
| [11] |
Lavery DL, Martinez P, Gay LJ, et al. Evolution of oesophageal adenocarcinoma from metaplastic columnar epithelium without goblet cells in Barrett's oesophagus [J]. Gut, 2016,65(6):907-913.
|
| [12] |
Tan WK, di Pietro M, Fitzgerald RC. Past, present and future of Barrett's oesophagus [J]. Eur J of Surg Oncol, 2017,43(7):1148-1160.
|
| [13] |
Falk GW, Rice TW, Goldblum JR, et al. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia [J]. Gastrointestinal Endosc, 1999, 49(2):170-176.
|
| [14] |
Sharma P, Hawes RH, Bansal A, et al. Standard endoscopy with random biopsies versus narrow band imaging targeted biopsies in Barrett's oesophagus: a prospective, international, randomised controlled trial [J]. Gut, 2012, 62(1):15-21.
|
| [15] |
Ngamruengphong S, Sharma VK, Das A. Diagnostic yield of methylene blue chromoendoscopy for detecting specialized intestinal metaplasia and dysplasia in Barrett's esophagus: a meta-analysis [J]. Gastrointest Endosc, 2009, 69(6):1021-1028.
|
| [16] |
Tholoor S, Bhattacharyya R, Tsagkournis O, et al. Acetic acid chromoendoscopy in Barrett's esophagus surveillance is superior to the standardized random biopsy protocol: results from a large cohort study (with video) [J]. Gastrointest Endosc, 2014, 80(3):417-424.
|
| [17] |
Sturm MB, Wang TD. Emerging optical methods for surveillance of Barrett's oesophagus [J]. Gut, 2015, 64(11):1816-1823.
|
| [18] |
Cobb MJ, Hwang JH, Upton MP, et al. Imaging of subsquamous Barrett's epithelium with ultrahigh-resolution optical coherence tomography: a histologic correlation study [J]. Gastrointestinal Endosc, 2010, 71(2):223-230.
|
| [19] |
Evans JA, Poneros JM, Bouma BE, et al. Optical coherence tomography to identify intramucosal carcinoma and high-grade dysplasia in Barrett's esophagus[J]. Clin Gastroenterol Hepatol, 2006, 4(1):38-43.
|
| [20] |
Swager AF, Boerwinkel DF, de Bruin DM, et al. Detection of buried Barrett's glands after radiofrequency ablation with volumetric laser endomicroscopy [J]. Gastrointest Endosc, 2016, 83(1):80-88.
|
| [21] |
di Pietro M, Boerwinkel DF, Shariff MK, et al. The combination of autofluorescence endoscopy and molecular biomarkers is a novel diagnostic tool for dysplasia in Barrett's oesophagus [J]. Gut, 2015, 64(1):49-56.
|
| [22] |
Spechler SJ. Barrett esophagus and risk of esophageal cancer: a clinical review [J]. JAMA, 2013, 310(6):627-636.
|
| [23] |
Gorospe EC, Wang KK. Risk stratification and surveillance in Barrett oesophagus [J]. Nature Re Gastroenterol Hepatol, 2014, 11(2):82-84.
|
| [24] |
Kastelein F, Biermann K, Steyerberg EW, et al. Aberrant p53 protein expression is associated with an increased risk of neoplastic progression in patients with Barrett's oesophagus [J]. Gut, 2013, 62(12):1676-1683.
|
| [25] |
Wani S, Rubenstein JH, Vieth M, et al. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association [J]. Gastroenterology, 2016, 151(5):822-835.
|
| [26] |
Duits LC, van der Wel MJ, Cotton CC, et al. Patients With Barrett's Esophagus and Confirmed Persistent Low-Grade Dysplasia Are at Increased Risk for Progression to Neoplasia [J]. Gastroenterology, 2017, 152(5):993-1001.
|
| [27] |
Sami SS, Ragunath K, Iyer PG. Screening for Barrett's Esophagus and Esophageal Adenocarcinoma: Rationale, Recent Progress, Challenges, and Future Directions [J]. Clin Gastroenterol Hepatol, 2015, 13(4):623-634.
|
| [28] |
Ross-Innes CS, Debiram-Beecham I, O'Donovan M, et al. Evaluation of a Minimally Invasive Cell Sampling Device Coupled with Assessment of Trefoil Factor 3 Expression for Diagnosing Barrett's Esophagus: A Multi-Center Case-Control Study [J]. PLOS Medicine, 2015,12(1):e1001780.
|
| [29] |
Kastelein F, Spaander MCW, Steyerberg EW, et al. Proton Pump Inhibitors Reduce the Risk of Neoplastic Progression in Patients With Barrett's Esophagus [J]. Clin Gastroenterol Hepatol, 2013, 11(4):382-388.
|
| [30] |
Kastelein F, Spaander MCW, Biermann K, et al. Nonsteroidal Anti- Inflammatory Drugs and Statins Have Chemopreventative Effects in Patients With Barrett's Esophagus [J]. Gastroenterology, 2011, 141(6):2000-2008.
|
| [31] |
Konda VJ, Gonzalez HRM, Koons A, et al. Complete endoscopic mucosal resection is effective and durable treatment for Barrett's-associated neoplasia [J]. Clin Gastroenterol Hepatol, 2014, 12(12):2002-2010.
|
| [32] |
Terheggen G, Horn EM, Vieth M, et al. A randomised trial of endoscopic submucosal dissection versus endoscopic mucosal resection for early Barrett's neoplasia [J]. Gut, 2017, 66(5):783-793.
|
| [33] |
Orman ES, Li N, Shaheen NJ. Efficacy and Durability of Radiofrequency Ablation for Barrett's Esophagus: Systematic Review and Meta-analysis [J]. Clin Gastroenterol Hepatol, 2013, 11(10):1245-1255.
|
| [34] |
Canto M, Shin E, Khashab M, et al. Safety and efficacy of carbon dioxide cryotherapy for treatment of neoplastic Barrett's esophagus[J]. Endoscopy, 2015, 47(7):591.
|